Next Article in Journal
Neuroprotective Nanoparticles Targeting the Retina: A Polymeric Platform for Ocular Drug Delivery Applications
Next Article in Special Issue
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose
Previous Article in Journal
Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems
Previous Article in Special Issue
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(4), 1095; https://doi.org/10.3390/pharmaceutics15041095
Action Date Notes Link
article xml file uploaded 29 March 2023 12:54 CEST Original file -
article xml uploaded. 29 March 2023 12:54 CEST Update https://www.mdpi.com/1999-4923/15/4/1095/xml
article pdf uploaded. 29 March 2023 12:54 CEST Version of Record https://www.mdpi.com/1999-4923/15/4/1095/pdf
article supplementary file uploaded. 29 March 2023 12:54 CEST - https://www.mdpi.com/1999-4923/15/4/1095#supplementary
article html file updated 29 March 2023 12:55 CEST Original file -
article html file updated 6 April 2023 23:31 CEST Update https://www.mdpi.com/1999-4923/15/4/1095/html
Back to TopTop